Healthcare provider profile · identity verified

Pushpendra Sharma, M.D.

Geriatric Medicine · NEW HYDE PARK, NY · NPI 1558422964

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	906	122
Losartan Potassium	Losartan Potassium	384	45
Amlodipine Besylate	Amlodipine Besylate	373	61
Levothyroxine Sodium	Levothyroxine Sodium	372	60
Eliquis	Apixaban	360	64
Gabapentin	Gabapentin	349	56
Mirtazapine	Mirtazapine	288	39
Furosemide	Furosemide	268	48
Metoprolol Succinate	Metoprolol Succinate	250	46
Pantoprazole Sodium	Pantoprazole Sodium	250	67
Carvedilol	Carvedilol	232	29
Metoprolol Tartrate	Metoprolol Tartrate	228	34
Clopidogrel	Clopidogrel Bisulfate	208	29
Hydralazine Hcl	Hydralazine Hcl	190	29
Famotidine	Famotidine	178	33
Metformin Hcl	Metformin Hcl	175	27
Escitalopram Oxalate	Escitalopram Oxalate	152	20
Donepezil Hcl	Donepezil Hcl	125	20
Montelukast Sodium	Montelukast Sodium	117	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	115	23
Januvia	Sitagliptin Phosphate	112	15
Nifedipine Er	Nifedipine	106	18
Omeprazole	Omeprazole	106	24
Trazodone Hcl	Trazodone Hcl	105	17
Tamsulosin Hcl	Tamsulosin Hcl	101	27
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	98	33
Latanoprost	Latanoprost	91	23
Sevelamer Carbonate	Sevelamer Carbonate	91	20
Torsemide	Torsemide	85	19
Midodrine Hcl	Midodrine Hcl	82	16
Duloxetine Hcl	Duloxetine Hcl	76	14
Potassium Chloride	Potassium Chloride	76	14
Carbidopa-Levodopa	Carbidopa/Levodopa	73	15
Finasteride	Finasteride	71	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	70	suppressed
Folic Acid	Folic Acid	68	16
Memantine Hcl	Memantine Hcl	67	18
Sertraline Hcl	Sertraline Hcl	65	14
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	63	11
Lisinopril	Lisinopril	63	suppressed
Levetiracetam	Levetiracetam	53	suppressed
Allopurinol	Allopurinol	52	suppressed
Xarelto	Rivaroxaban	52	suppressed
Baclofen	Baclofen	51	suppressed
Haloperidol	Haloperidol	51	suppressed
Divalproex Sodium	Divalproex Sodium	49	suppressed
Nystatin	Nystatin	47	17
Buspirone Hcl	Buspirone Hcl	46	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	46	suppressed
Lovastatin	Lovastatin	45	suppressed
Admelog Solostar	Insulin Lispro	41	20
Amiodarone Hcl	Amiodarone Hcl	41	11
Metformin Hcl Er	Metformin Hcl	41	suppressed
Clonidine	Clonidine	40	suppressed
Labetalol Hcl	Labetalol Hcl	40	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	40	suppressed
Santyl	Collagenase Clostridium Hist.	40	13
Sucralfate	Sucralfate	40	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	suppressed
Spironolactone	Spironolactone	39	suppressed
Insulin Aspart Flexpen	Insulin Aspart	38	suppressed
Repaglinide	Repaglinide	34	suppressed
Enalapril Maleate	Enalapril Maleate	33	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	31	suppressed
Methimazole	Methimazole	31	suppressed
Glipizide	Glipizide	29	suppressed
Incruse Ellipta	Umeclidinium Bromide	29	suppressed
Novolog Flexpen	Insulin Aspart	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Digoxin	Digoxin	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	12
Cilostazol	Cilostazol	27	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	27	suppressed
Procrit	Epoetin Alfa	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Anastrozole	Anastrozole	24	suppressed
Bumetanide	Bumetanide	24	suppressed
Cephalexin	Cephalexin	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	11
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Methenamine Hippurate	Methenamine Hippurate	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Valsartan	Valsartan	24	suppressed
Albuterol Sulfate	Albuterol Sulfate	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Timolol Maleate	Timolol Maleate	23	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	22	22
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Atenolol	Atenolol	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Amantadine	Amantadine Hcl	20	suppressed
Ssd	Silver Sulfadiazine	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Mexiletine Hcl	Mexiletine Hcl	18	suppressed
Ranolazine Er	Ranolazine	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Metolazone	Metolazone	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Simvastatin	Simvastatin	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Linzess	Linaclotide	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Prednisolone Acetate	Prednisolone Acetate	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Lactulose	Lactulose	11	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error